With no evidence for aberrant NKG2DL presence among lupus B cells we thus considered myelomonocytic cells as possible NKG2DL source for NKG2D+CD4 T cell activation and expanded the flow cytometry-based screen to lupus monocytes. This evidence concerns the gene KLRK1 and systemic lupus erythematosus.